|
Thompson, Paul M; Bartzokis, George; Hayashi, Kiralee M et al. (2009) Time-lapse mapping of cortical changes in schizophrenia with different treatments. Cereb Cortex 19:1107-23
|
|
Green, A I; Lieberman, J A; Hamer, R M et al. (2006) Olanzapine and haloperidol in first episode psychosis: two-year data. Schizophr Res 86:234-43
|
|
Perkins, Diana O; Johnson, Jacqueline L; Hamer, Robert M et al. (2006) Predictors of antipsychotic medication adherence in patients recovering from a first psychotic episode. Schizophr Res 83:53-63
|
|
Lieberman, Jeffrey A; Tollefson, Gary D; Charles, Cecil et al. (2005) Antipsychotic drug effects on brain morphology in first-episode psychosis. Arch Gen Psychiatry 62:361-70
|
|
Lieberman, Jeffrey A; Tollefson, Gary; Tohen, Mauricio et al. (2003) Comparative efficacy and safety of atypical and conventional antipsychotic drugs in first-episode psychosis: a randomized, double-blind trial of olanzapine versus haloperidol. Am J Psychiatry 160:1396-404
|
|
Green, Alan I; Burgess, Ellen S; Dawson, Ree et al. (2003) Alcohol and cannabis use in schizophrenia: effects of clozapine vs. risperidone. Schizophr Res 60:81-5
|
|
Zimmet, S V; Strous, R D; Burgess, E S et al. (2000) Effects of clozapine on substance use in patients with schizophrenia and schizoaffective disorder: a retrospective survey. J Clin Psychopharmacol 20:94-8
|
|
Green, A I; Zimmet, S V; Strous, R D et al. (1999) Clozapine for comorbid substance use disorder and schizophrenia: do patients with schizophrenia have a reward-deficiency syndrome that can be ameliorated by clozapine? Harv Rev Psychiatry 6:287-96
|
|
Green, A I; Schildkraut, J J (1995) Should clozapine be a first-line treatment for schizophrenia? The rationale for a double-blind clinical trial in first-episode patients. Harv Rev Psychiatry 3:1-9
|
